Peer-influenced content. Sources you trust. No registration required. This is HCN.
Hematology Advisor
Retrospective analysis of pediatric cancer survivors identified low overall CHIP prevalence, with antimetabolite therapy and methotrexate exposure emerging as the strongest treatment-associated signals.
Hematology May 12th 2026
Consultant360
A 55-year-old man with bilateral hand arthritis, ruddy complexion, and elevated transferrin saturation presents a diagnostic reasoning challenge with implications for screening, surveillance, and family testing.
Family Medicine/General Practice May 8th 2026
DAGO2 produced 3-year overall survival of 52% versus 35% with CPX-351 in older patients with non-adverse-risk AML in a 439-patient randomized comparison.
Hematology April 28th 2026
Mayo Clinic Labs
Hereditary TTP, an ultra-rare ADAMTS13 deficiency affecting roughly one in a million, is now managed with weekly recombinant ADAMTS13 infusions in a pediatric outpatient setting.
Medical Xpress
The new method, called MethylScan, works by analyzing cell-free DNA (cfDNA), which carries molecular signals that reflect what is happening throughout the body.
Hematology April 14th 2026
Medical Professionals Reference (MPR)
A patient harmed by their own noncompliance may still file a medical malpractice case. Luckily, though, with proper record-keeping you can generally prevail in this sort of case.
Cardiology April 10th 2026
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS